External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort

Background: External validation of risk calculators (RCs) is necessary to determine their clinical applicability beyond the setting in which these were developed. Objective: To assess the performance of the Rotterdam Prostate Cancer RC (RPCRC) and the Prostate Biopsy Collaborative Group RC (PBCG-RC)...

Full description

Bibliographic Details
Main Authors: Jan Chandra Engel, Thorgerdur Palsdottir, Donna Ankerst, Sebastiaan Remmers, Ashkan Mortezavi, Venkatesh Chellappa, Lars Egevad, Henrik Grönberg, Martin Eklund, Tobias Nordström
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:European Urology Open Science
Subjects:
Prostate cancer
Risk calculators
External validation study
Recalibration of risk prediction tools
Prostate cancer screening
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168322005857

Internet

http://www.sciencedirect.com/science/article/pii/S2666168322005857

Similar Items